APAC

Oncology

Australia, CAR-T therapy, and solid tumours

Bev Menner, chief executive officer at Cell Therapies Pty Ltd, discusses CAR-T therapies for solid tumours and Australian and APAC R&D more generally.

Digital

Australia, AI, and Autolomous

pharmaphorum spoke with Alexander Seyf, CEO of Autolomous, about the future of AI in Australian biotech.

Market Access

South Korea: Emerging global leader in life sciences

South Korea has designated life sciences and biotechnology as priority areas for growth and leadership.

Market Access

China’s 4+7 drug procurement policy and its impact on the ph...

It is estimated that China has around 10,000 pharmaceutical companies varying in size, strategy, and technology.

News

Project seeks to shape digital health reimbursement in APAC

APACMed and Eversana join forces to draw up coverage frameworks applicable to APAC countries.

Oncology

Close-up of East and Southeast Asia in the colorful world map.

Country focus: China & APAC’s growing medical needs bring op...

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market.